Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Papillomavirus Infection: later-stage trial registry
3 of 4 indexed Papillomavirus Infection trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 3 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Papillomavirus Infection: 4 US clinical trials tracked, 3 recruiting.
Papillomavirus Infection is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Louisiana State University Health Sciences Center in New Orleans, running 1 of these trials.
Enrollment posture brief
Registry condition papillomavirus-infection
OPEN 3 | RECR 75% | LATE 2 | EARLY 1 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Activity, Motor (75% recruiting · 8 trials)
Papillomavirus Infection lists 3 open slots (75% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Papillomavirus Infection on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Papillomavirus Infection is recruiting above its size-band peers.
3 of 4 indexed trials (75%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Marengo Therapeutics
NCT05592626
Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV
Louisiana State University Health Sciences Center in New Orleans
NCT05266898
Zopa Retreatment and Vector Shedding in Adults With RRP
Precigen
NCT06538480
HPV Self-Sampling in Somali Women (Isbaar Project)
University of Minnesota
NCT05453006
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Papillomavirus Infection records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Papillomavirus Infection trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Papillomavirus Infection page
4 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Papillomavirus Infection trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Louisiana State University Health Sciences Center in New Orleans sponsors the most Papillomavirus Infection trials on record, review their full trial history before evaluating a specific study. See Louisiana State University Health Sciences Center in New Orleans's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Papillomavirus Infection condition card totals 4 registered trials; most-linked intervention COPAN 552c.80 FLOQSwab; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.